1932

Abstract

The discovery and development of more than a dozen drugs in the past 15 years for the treatment of AIDS offer an excellent example of progress in the field of rational drug design. At this time, the principal targets are reverse transcriptase and protease, enzymes encoded by the human immunodeficiency virus. The introduction of protease inhibitors, in particular, has drastically decreased the mortality and morbidity associated with AIDS. This review presents the methods used to develop such drugs and discusses the remaining problems, such as the rapid emergence of drug resistance.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.53.052901.131947
2002-02-01
2024-06-17
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.53.052901.131947
Loading
/content/journals/10.1146/annurev.med.53.052901.131947
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error